BioLumic, Inc.
Palmerston North · Founded 2020 · Delaware corporation · 9 known investors
Uses UV light signals to boost seed and seedling genetic potential; domiciled in the USA.
Founders & leadership
BioLumic, Inc. was founded in 2020 by Jason Wargent.
JW
Jason WargentFounder
SS
Steven SibulkinExecutive
MB
Mark BrownNamed on SEC filing
MD
Mary DimouNamed on SEC filing
JB
John BedbrookNamed on SEC filing
KB
Kirsty BellringerNamed on SEC filing
DH
David HollinrakeNamed on SEC filing
GL
Greg LevowNamed on SEC filing
Board
AP
DT
Dean TilyardBoard director
JW
Johanna WolfsonBoard director
Investors · 9
Reported raises · per SEC filings
Form D private placements$22.1M disclosed across 3 rounds · 2021–2026
▶$8.3MraisedAug 2026 · 8 investors · Other TechnologyRule 506(b)
▶$8.3MraisedAug 2026 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Steven SibulkinExecutive Officer, Director
- Jason WargentExecutive Officer, Director
- Kirsty BellringerDirector
- Adrian PercyDirector
- Johanna WolfsonDirector
- David HollinrakeDirector
- Greg LevowExecutive Officer
- Offering amount
- $22.1M
- Amount sold
- $8.3M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.5MraisedMar 2022 · 25 investors · Other TechnologyRule 506(b)
▶$12.5MraisedMar 2022 · 25 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mark BrownDirector
- Richard PerryExecutive Officer
- Steven SibulkinExecutive Officer, Director
- John BedbrookDirector
- Mary DimouDirector
- Adrian PercyDirector
- Eli NirDirector
- Dean TilyardDirector
- Jason WargentExecutive Officer
- Offering amount
- $19M
- Amount sold
- $12.5M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.3MraisedDec 2021 · 7 investors · Other TechnologyRule 506(b)
▶$1.3MraisedDec 2021 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mark BrownDirector
- Mary DimouDirector
- Adrian PercyDirector
- Steven SibulkinExecutive Officer, Director
- John BedbrookDirector
- Jason WargentExecutive Officer
- Dean TilyardDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapLumen4 shared keywordsLumen develops orally-delivered biologic drugs using genetically engineered spirulina algae, which expresses therapeutic proteins such as enzymes, antibodies, and cytokines that are spray-dried into shelf-stable powders and capsules. Its pipeline targets conditions including weight loss, C. difficile, Crohn's disease, ulcerative colitis, and respiratory infections.
Steam3 shared keywordsSteam is a digital distribution platform for purchasing, downloading, and playing PC video games, operated by Valve. It serves gamers worldwide and offers a client application with multi-language support.
Companies competing with BioLumic, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does BioLumic, Inc. do?
- Uses UV light signals to boost seed and seedling genetic potential; domiciled in the USA.
- Who founded BioLumic, Inc.?
- BioLumic, Inc. was founded by Jason Wargent in 2020.
- Who are BioLumic, Inc.'s investors?
- BioLumic, Inc.'s investors include Angel HQ, Arc Angels, Azolla Ventures, Booster Innovation Fund, Icehouse Ventures, iSelect Fund, Nelson Angels, Radicle Growth and 1 more.
- How much funding has BioLumic, Inc. raised?
- BioLumic, Inc. has disclosed $22.1M raised across 3 rounds.
- Where is BioLumic, Inc. headquartered?
- BioLumic, Inc. is headquartered in Palmerston North.